Weaver C. Barksdale & Associates, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001294588

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallDiversifiedHigh Turnover how tags are computed

Q4 2024 · 62 positions · Total reported value $104.49M · Top-10 concentration 22.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 96.8% · 1 new · 59 cut · 1 exited

Active Share (vs S&P 500): 86.5% · vs QQQ: 89.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.5% · vs SPY -2.6% · Prev Value $111.47M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +7.6% · vs SPY +5.5% · Latest Value $109.47M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Weaver C. Barksdale & Associates, Inc. disclosed 62 equity positions with a combined reported value of $104.49M. The filing implies a diversified portfolio: its ten largest positions account for 22.8% of reported value. HoldingsHub classifies the profile as Small / Diversified / High Turnover.

The largest disclosed positions as of Q4 2024 were ORI ($2.55M), AVGO ($2.53M), PKG ($2.49M). By sector, the heaviest allocations are Financials 25.2%, Industrials 14.5%. Versus the prior quarter, allocation shifted toward Financials (+3.1pp), Health Care (+0.9pp) and away from Consumer Staples (-1.0pp), Industrials (-1.3pp).

Versus the prior quarter, Weaver C. Barksdale & Associates, Inc. opened 1 new positions, trimmed 59 and fully exited 1, a turnover rate of 96.8% of positions. The portfolio's overlap with the prior quarter was 91% of names.

The largest new positions opened in Q4 2024 were UNM ($1.94M), ELV ($1.77M), SIRI ($1.15M).

Of the 1 positions fully exited versus the prior quarter, the largest were IPG ($1.56M), CVS ($1.07M), PFE ($924.97K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • UNM UNUM GROUP · $1.94M
  • ELV ELEVANCE HEALTH INC FORMERLY · $1.77M
  • SIRI SIRIUSXM HOLDINGS INC · $1.15M

Fully Exited (vs previous quarter)

  • IPG INTERPUBLIC GROUP COS INC · prev qtr: $1.56M
  • CVS CVS HEALTH CORP · prev qtr: $1.07M
  • PFE PFIZER INC · prev qtr: $924.97K

Insider Transactions (Form 4)

Latest Weaver C. Barksdale & Associates, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Weaver C. Barksdale & Associates, Inc. is an SEC-registered 13F filer based in Nashville, TN, United States. As of Q2 2026 it reported 62 US equity positions with a combined value of $111.47M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NASHVILLE, TN, United States
  • SEC registration: 801-23126 (status: Approved), registered 1984-12-27
  • Regulatory AUM (Form ADV): $3.01B as of 2026-07-14
  • Client mix (by RAUM): pension and profit-sharing plans 87%, pooled investment vehicles 13%
  • Website: barksdaleim.com

Portfolio Structure

  • 62 positions · $111.47M reported value (Q2 2026)
  • Top 10 holdings = 22.1% of reported value
  • Largest position: CMI (CUMMINS INC) at 2.4%
  • Average position size: $1.80M

Sector Tilt

  • Financials 23.1%
  • Consumer Discretionary 17.2%
  • Health Care 14.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 added, 6 reduced, 1 exited
  • 54 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 25.2%
Industrials 14.5%
Health Care 13.2%
Technology 7.9%
Energy 7.6%
Utilities 5.0%
Other 8.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 70.49K $2.55M 2.44%
2.44%
Reduce
2 10.93K $2.53M 2.42%
2.42%
Reduce
3 11.08K $2.49M 2.39%
2.39%
Reduce
4 7.01K $2.45M 2.34%
2.34%
Reduce
5 4.45K $2.37M 2.27%
2.27%
Reduce
6 9.75K $2.34M 2.24%
2.24%
Reduce
7 22.41K $2.32M 2.22%
2.22%
Reduce
8 15.93K $2.29M 2.19%
2.19%
Reduce
9 6.73K $2.28M 2.19%
2.19%
Reduce
10 18.92K $2.24M 2.15%
2.15%
Reduce
11 5.29K $2.23M 2.13%
2.13%
Reduce
12 29.85K $2.21M 2.12%
2.12%
Reduce
13 35.95K $2.20M 2.10%
2.10%
Reduce
14 23.66K $2.19M 2.09%
2.09%
Reduce
15 8.57K $2.12M 2.03%
2.03%
Reduce
16 25.81K $2.11M 2.02%
2.02%
Reduce
17 28.54K $2.05M 1.96%
1.96%
Reduce
18 11.44K $2.03M 1.95%
1.95%
Reduce
19 4.18K $2.03M 1.95%
1.95%
Reduce
20 7.63K $2.01M 1.92%
1.92%
Reduce
21 26.49K $1.94M 1.85%
1.85%
New
22 7.57K $1.92M 1.84%
1.84%
Reduce
23 13.76K $1.86M 1.78%
1.78%
Reduce
24 42.88K $1.82M 1.74%
1.74%
Reduce
25 49.51K $1.80M 1.72%
1.72%
Reduce
26 11.57K $1.78M 1.70%
1.70%
Reduce
27 22.90K $1.77M 1.70%
1.70%
Add
28 4.80K $1.77M 1.70%
1.70%
New
29 6.79K $1.77M 1.70%
1.70%
Reduce
30 29.22K $1.73M 1.66%
1.66%
Reduce
31 15.67K $1.73M 1.65%
1.65%
Reduce
32 13.65K $1.72M 1.65%
1.65%
Reduce
33 11.64K $1.69M 1.61%
1.61%
Reduce
34 8.97K $1.68M 1.61%
1.61%
Reduce
35 10.53K $1.66M 1.59%
1.59%
Reduce
36 29.30K $1.66M 1.59%
1.59%
Reduce
37 13.45K $1.65M 1.58%
1.58%
Reduce
38 30.83K $1.65M 1.58%
1.58%
Reduce
39 13.85K $1.58M 1.51%
1.51%
Reduce
40 8.97K $1.52M 1.45%
1.45%
Reduce
41 26.50K $1.50M 1.44%
1.44%
Add
42 25.69K $1.37M 1.31%
1.31%
Reduce
43 29.24K $1.36M 1.30%
1.30%
Reduce
44 14.70K $1.33M 1.28%
1.28%
Reduce
45 35.47K $1.33M 1.27%
1.27%
Reduce
46 15.38K $1.32M 1.26%
1.26%
Reduce
47 17.42K $1.29M 1.24%
1.24%
Reduce
48 13.95K $1.27M 1.22%
1.22%
Reduce
49 10.44K $1.22M 1.17%
1.17%
Reduce
50 8.66K $1.21M 1.16%
1.16%
Reduce

FAQ

What did Weaver C. Barksdale & Associates, Inc. buy in 2024-Q4?

In its 2024-Q4 13F filing, Weaver C. Barksdale & Associates, Inc. reported 62 equity positions worth $104.49M in aggregate; its largest disclosed positions were ORI ($2.55M), AVGO ($2.53M), PKG ($2.49M).

How large is Weaver C. Barksdale & Associates, Inc.'s portfolio?

Weaver C. Barksdale & Associates, Inc. reported $104.49M of long equity holdings across 62 positions as of 2024-Q4. Top-10 holdings account for 22.8% of reported value.

What is Weaver C. Barksdale & Associates, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/weaver-c-barksdale-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →